İnfertil kadınlarda ioheksol kullanılarak yapılan histerosalpingografi tetkiki sonrası tiroid fonksiyonlarının değerlendirilmesi

Abstract

Giriş ve Amaç: Suda çözünen non–iyonik radyoopak madde olan ioheksol (Omnipaque^TM) kullanılarak çekilen histerosalpingografi (HSG) öncesi ve sonrası serum serbest T3 (triiodotironin), serbest T4 (tiroksin) ve TSH düzeylerindeki değişiklikleri araştırmak.

Gereç ve Yöntem: Prospektif olarak tasarlanan bu çalışma Ocak 2015 ve Mart 2015 tarihleri arasında Zekai Tahir Burak Kadın Sağlığı Eğitim ve Araştırma Hastanesi infertilite polikliniğine başvuran 45 infertil ötiroid hastada gerçekleştirildi. Hepatik hastalık, renal yetmezlik ve akut enfeksiyonu olan hastalarla tiroid hastalığı öyküsü olan ve lityum, amiadaron ve glukokortikoid gibi antitiroid ilaç kullanan hastalar çalışma dışında bırakıldı. Menstrüasyonları tamamlanan ve gebe olmadıkları gösterilen tüm hastaların HSG öncesi ve HSG sonrası 1. ayda serum serbest T3, serbest T4 ve TSH düzeyleri ölçüldü.

Bulgular: Çalışmaya dahil edilen hastaların yaş ortalaması 28,3±5,5 (20–40) olarak hesaplandı. İşlem öncesi serbest T3, serbest T4 ve TSH düzeyleri sırasıyla, 3,0±0,4pg/mL, 1,0±0,2 ng/dL, 2,2±1,5 mIU/mL iken işlem sonrası, 3,1±0,3 pg/mL, 0,9±0,8 ng/dL, 1,9±0,9 mIU/mL olarak ölçüldü. Serbest T4 ve TSH düzeylerindeki azalma istatistiksel olarak anlamlı bulunurken (p=0,016, p=0,026), serbest T3’deki azalma istatistiksel olarak anlamsızdı (p=0,083).

Sonuç: Her ne kadar yarılanma ömrü dakikalarla sınırlı olsa da ioheksol kullanılarak çekilen HSG sonrası infertil kadınlarda tiroid fonksiyonlarında değişiklik meydana gelmektedir. Bu hastalarda işlem sonrası gelişebilecek tiroid disfonksiyonu akılda bulundurulmalıdır.

Keywords

• Histerosalpingografi,iyot,kontrast madde,tiroid fonksiyon testi

Evaluation of thyroid functions after hysterosalpingography using iohexol in infertile women

Abstract

Introduction and Aim: To investigate the changes in serum free T3 (triiodothyronine), free T4 (thyroxine) and TSH levels before and after hysterosalpingography (HSG) using iohexol (Omnipaque ™), a water-soluble non-ionic radiopaque substance.

 

Material and Methods: This prospective study was conducted in 45 infertile euthyroid patients who applied to the infertility polyclinic of Zekai Tahir Burak Women's Health Education and Research Hospital between January 2015 and March 2015. Patients with hepatic disease, renal insufficiency and acute infection, patients with thyroid disease and those using antithyroid drugs such as lithium, amiadarone and glucocorticoid were excluded from the study. Serum free T3, free T4 and TSH levels were measured before HSG and at 1 month after HSG in all patients whose menstruation was completed and who were shown not to be pregnant. 

 

Results: The mean age of the patients included in the study was calculated as 28.3 ± 5.5 (20-40). The free T3, free T4 and TSH levels before the procedure were 3,0 ± 0,4 pg / mL, 1,0 ± 0,2 ng / dL, 2,2 ± 1,5 mIU / mL, respectively, 3,1± 0.3 pg / mL, 0.9 ± 0.8 ng / dL, 1.9 ± 0.9 mIU / mL, respectively. While the decrease in free T4 and TSH levels was statistically significant (p = 0.016, p = 0.026), the decrease in free T3 was statistically insignificant (p = 0.083).

 

Conclusion: Though the half-life is limited to a few minutes, changes in thyroid function occur in infertile women after HSG using iohexol. In these patients, thyroid dysfunction which may develop after the procedure should be kept in mind.

 

Keywords

• Hysterosalpyngography,iodine,contrast agent,thyroid function test

References

1. 1. Abdullah BJJ, Ng KH, Rassiah P. A comparison of radiation dose and image quality in hysterosalpingography using conventional and high kilovolt techniques. J HK Coll Radiol 2001;4:133-136.
2. 2. Intravascular contrast media. in: Stephan C, Richard N eds. A guide to radiological procedure. Edinburgh, UK: WB Saunders, 2001:27-40.
3. 3. Mekaru K, Kamiyama S, Masamoto H, et al. Thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium. Gynecol Endocrinol 2008;24:498–501.
4. 4. Lindequist S, Justesen P, Larsen C et al. Diagnostic quality and complications of hysterosalpingography: oil- versus water-soluble contrast media--a randomized prospective study. Radiology 1991;179(1):69-74.
5. 5. Lindequist S, Rasmussen F, Larsen C. Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography. Radiology 1994;191(2):513-517.
6. 6. H Mohd Nor, KJ Jayapragasam, BJJ Abdullah. Diagnostic image quality of hysterosalpingography: ionic versus non ionic water soluble iodinated contrast media. Available online at http://www.biij.org/2009/3/e29 doi: 10.2349/biij.5.3.e29.
7. 7. Han H, Xin P, Zhao L, Xu J, Xia Y, Yang X, Sun X, Hao L. Excess iodine and high-fat diet combination modulates lipid profile, thyroid hormone, and hepatic LDLr expression values in mice. Biol Trace Elem Res 2012; 147: 233-239.
8. 8. Hussein Ael-A, Abbas AM, El Wakil GA, Elsa- manoudy AZ, El Aziz AA. Effect of chronic excess iodine intake on thyroid function and oxidative stress in hypothyroid rats. Can J Physiol Pharmacol 2012; 90: 617-625.

9. 9. Basalaeva NL. Iodine-induced thyroid blockade: role of selenium and iodine in the thyroid and pituitary glands. Biol Trace Elem Res 2013; 154: 244-254.
10. 10. Shuhei So, Wakasa Yamaguchi, Hiroko Tajima, Takeshi Nakayama, Naoaki Tamura, Naohiro Kanayama & Fumiko Tawara. The effect of oil and water-soluble contrast medium in hysterosalpingography on thyroid function. Gynecological Endocrinology; 2017.
11. 11. Nishiyama S, Mikeda T, Okada T, et al. Transient hypothyroidism or persistent hyperthyrotropinemia in neonates born to mothers with excessive iodine intake. Thyroid 2004;14:1077–1083.
12. 12. Sasaki Y, Kikuchi A, Murai M, et al. Fetal goiter associated with preconception hysterosalpingography using an oil-soluble iodinated contrast medium. Ultrasound Obstet Gynecol 2016;10:15902.
13. 13. Kaneshige T, Arata N, Harada S, et al. Changes in serum iodine concentration, urinary iodine excretion and thyroid function after hysterosalpingography using an oil-soluble iodinated contrast medium (lipiodol). J Clin Endocrinol Metab 2015;100:E469–472.
14. 14. Schneuer FJ, Nassar N, Tasevski V, et al. Association and predictive accuracy of high TSH serum levels in first trimester and adverse pregnancy outcomes. J Clin Endocrinol Metab 2012;97:3115–122.
15. 15. Negro R, Schwartz A, Gismondi R, et al. Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 2.5 and 5.0 in the first trimester of pregnancy. J Clin Endocrinol Metab 2010;95:E44–48.
16. 16. Su PY, Huang K, Hao JH, Xu YQ, Yan SQ, Li T, Xu YH, Tao FB. Maternal thyroid function in the first twenty weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in China. J Clin Endocrinol Metab 2011; 96: 3234-41.
17. 17. Van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011;17:605–19.